Does MEPOLIZUMAB Cause Secretion discharge? 359 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 359 reports of Secretion discharge have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.8% of all adverse event reports for MEPOLIZUMAB.
359
Reports of Secretion discharge with MEPOLIZUMAB
0.8%
of all MEPOLIZUMAB reports
9
Deaths
137
Hospitalizations
How Dangerous Is Secretion discharge From MEPOLIZUMAB?
Of the 359 reports, 9 (2.5%) resulted in death, 137 (38.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Secretion discharge Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 359 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Secretion discharge?
ADALIMUMAB (685)
DUPILUMAB (626)
ALBUTEROL (520)
OMALIZUMAB (514)
ETANERCEPT (487)
METHOTREXATE (387)
BUDESONIDE\FORMOTEROL (339)
PREDNISONE (316)
SECUKINUMAB (307)
TREPROSTINIL (297)
Which MEPOLIZUMAB Alternatives Have Lower Secretion discharge Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE